Yahoo Web Search

Search results

1. Videos

   • 4:36

     youtube.com

     Introducing Trial Management at Novartis, Careers with Purpose

     26 Feb 2021

     827 views

   • 2:59

     youtube.com

     25 Years of Novartis – Continuing our innovation journey

     2 Mar 2021

     30.3K views

   • 1:09

     youtube.com

     Careers within Medical Affairs at Novartis

     19 Apr 2024

     5.4K views

   View all

2. endpts.com › acquired-biotech-accuses-novartis-of-letting-ilAcquired biotech accuses Novartis of letting IL-15 asset ‘wither...

   endpts.com › acquired-biotech-accuses-novartis-of-letting-il

   • Cached

   4 hours ago · Max Bayer. Pharma Reporter. No­var­tis is be­ing ac­cused of de­lib­er­ate­ly stalling the de­vel­op­ment of an ac­quired IL-15 as­set, cost­ing a small­er biotech up to $940 mil ...

3. medicaex.com › prnewswire › biocity-announces-its-endothelinBioCity announces its endothelin receptor A selective antagonist...

   medicaex.com › prnewswire › biocity-announces-its-endothelin

   • Cached

   Jul 9, 2024 · SHANGHAI, July 8, 2024 /PRNewswire/ -- BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in the 2-SUCCEED trial: a randomized, double-blind, placebo-controlled, dose-ranging phase 2 clinical trial of SC0062 in chronic kidney disease (CKD). The study is ongoing in the diabetic kidney disease ...

4. www.finanzen.ch › nachrichten › aktienNovartis Aktie News: Novartis zeigt sich am Montagnachmittag...

   www.finanzen.ch › nachrichten › aktien

   • Cached

   23 hours ago · Die Aktie von Novartis zählt am Montagnachmittag zu den Gewinnern des Tages. Zuletzt stieg die Novartis-Aktie. In der SIX SX-Sitzung kletterte das Papier um 0,7 Prozent auf 97,31 CHF.

5. nl.marketscreener.com › BULL-CERTIFICATE-NOVARTIS-169128057BULL CERTIFICATE - NOVARTIS N: koers Certificat beurs| YGDABP ...

   nl.marketscreener.com › BULL-CERTIFICATE-NOVARTIS-169128057

   • Cached

   23 hours ago · BULL CERTIFICATE - NOVARTIS N: beurskoers, grafieken, koersen, beursadviezen, financiële gegevens, analyses en real time nieuws Certificat BULL CERTIFICATE - NOVARTIS N | YGDABP | CH1346746246 | Swiss Exchange

6. www.real.gr › synenteukseis › arthroΟ Δ. Καλαματιανός στην εκπομπή των Κ. Μακρή – Μ. Νιφλή (8/7/2024)

   www.real.gr › synenteukseis › arthro

   • Cached

   23 hours ago · Σε εξέλιξη φωτιά σε χαμηλή βλάστηση στην περιοχή Βρανάς στον Μαραθώνα. Δύο μέτωπα πυρκαγιάς εκδηλώθηκαν στο Μαρκόπουλο, ένα εκ των οποίων έχει τεθεί υπό έλεγχο.

7. www.openpr.com › news › 3570420Major Player in the Pharmaceutical R&D Technologies Market -...

   www.openpr.com › news › 3570420

   10 hours ago · Press release - WMR - Major Player in the Pharmaceutical R&D Technologies Market Analysis by Type, Application, Growth, Demand, Status, and Forecast From 2024 to 2031: Sanofi, Pfizer, Novartis ...